Chile vs Ecuador: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Ecuador
100.0%
in 2024
Chile rank
1st
Ecuador rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Ecuador
How they compare
Chile currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Ecuador ahead.
Chile ranks 1st and Ecuador ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Ecuador in 2.
Head to head by decade
| Decade | Chile | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 3.4% | 0.1% | Ecuador |
| 2010s | 45.7% | 21.7% | 24.0% | Chile |
| 2020s | 95.2% | 95.8% | 0.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Ecuador?
- Chile, at 100.0% against 100.0% in Ecuador as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Ecuador?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Ecuador?
- 16 years are reported by both, from 2005 to 2024.
- How do Chile and Ecuador rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Ecuador ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.